Pfizer News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

24.06.20	Pfizer and Wellcome Launch Surveillance Program to Combat Growing Threat of Antimicrobial Resistance in Sub-Saharan Africa (Businesswire)
22.06.20	Pfizer Starts Four Phase 3 Trials For Investigational Vaccines (RTTNews)
22.06.20	Pfizer Announces Start of Four Phase 3 Clinical Trials for Investigational Vaccines (Businesswire)
22.06.20	Children's Cough Syrups Recalled For Faulty Dosing Cups (RTTNews)
18.06.20	Pfizer, Sangamo: Follow-up Data Affirm Findings Of Phase 1/2 Giroctocogene Fitelparvovec Study (RTTNews)
18.06.20	Upjohn Announces Pricing of Senior Notes in Connection with the Proposed Combination of Mylan and Upjohn (Businesswire)
16.06.20	Pfizer Invites Public to View and Listen to Webcast of July 28 Conference Call with Analysts (Businesswire)
13.06.20	Race For COVID-19 Vaccine: Who Are The Key Players? (RTTNews)
12.06.20	Pfizer Invites Public to View and Listen to Webcast of June 18 Conference Call with Analysts to Review Data Presentations at Scientific Conferences during the Week of June 15th (Businesswire)
11.06.20	Pfizer : FDA Approves Oncology Supportive Care Biosimilar, NYVEPRIA (RTTNews)
10.06.20	Pfizer Announces Positive Top-Line Results from JADE TEEN Trial of Abrocitinib in Adolescents with Moderate-to-Severe Atopic Dermatitis (Businesswire)
09.06.20	Amphastar: FDA Approves Succinylcholine Chloride Injection Multiple-Dose Vial (RTTNews)
04.06.20	List Of 'Operation Warp Speed' Finalists, SAVA To Reassess AD Study Results; KZR Jumps On MISSION (RTTNews)
03.06.20	Complete Results from Second Pivotal Monotherapy Study of Abrocitinib Published in JAMA Dermatology (Businesswire)
02.06.20	Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference (Businesswire)
02.06.20	Pfizer Establishes New Program to Support Continued Biotechnology Innovation (Businesswire)
30.05.20	Pfizer Says Breast Cancer Trial Unlikely To Be Effective (RTTNews)
29.05.20	Pfizer Provides Update on Phase 3 PALLAS Trial of IBRANCE® (palbociclib) Plus Endocrine Therapy in HR+, HER2- Early Breast Cancer (Businesswire)
29.05.20	Pfizer, Astellas Say Final PROSPER Results Show XTANDI Extends Overall Survival (RTTNews)
22.05.20	Pfizer Inc. Recommends Rejection of Unsolicited Note Tender Offer by Huguenot Bond Liquidity, LLC (Businesswire)
19.05.20	Pfizer Prices $4,000,000,000 Debt Offering (Businesswire)
18.05.20	GSK: ViiV Healthcare HIV Prevention Study Shows Higher Efficacy (RTTNews)
15.05.20	Pfizer's Phase 1b Results On DMD Support Advancement Into Pivotal Phase 3 Study (RTTNews)
15.05.20	Pfizer: Phase 1b Data On PF-06939926 Support Advancement Into Phase 3 Study (RTTNews)
15.05.20	Pfizer’s New Phase 1b Results of Gene Therapy in Ambulatory Boys with Duchenne Muscular Dystrophy (DMD) Support Advancement into Pivotal Phase 3 Study (Businesswire)
14.05.20	Pfizer Announces Positive Results On 20-Valent Pneumococcal Conjugate Vaccine (RTTNews)
14.05.20	Pfizer Announces Positive Top-Line Results From Phase 3 Lot Consistency Study of 20-Valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-Naive Adults 18 Through 49 Years of Age (Businesswire)
13.05.20	Save the Date: Pfizer Announces New Date of September 14, 2020 for Rescheduled Investor Day (Businesswire)
12.05.20	New Data from 18 Approved and Investigational Pfizer Medicines to be Showcased at ASCO20 Virtual Scientific Program (Businesswire)
12.05.20	Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference (Businesswire)
08.05.20	Pfizer Invites Public to View and Listen to Webcast of May 15 Conference Call with Analysts to Review Duchenne Muscular Dystrophy (DMD) Data Presentation at ASGCT 2020 Annual Meeting (Businesswire)
05.05.20	Pfizer Starts Human Trials Of Potential Coronavirus Vaccine In U.S. (RTTNews)
05.05.20	Pfizer and BioNTech Dose First Participants in the U.S. as Part of Global COVID-19 mRNA Vaccine Development Program (Businesswire)
04.05.20	New Data Suggest Burden of Group B Streptococcus (GBS) Infection in U.S. Adults Greater Than Previously Recognized (Businesswire)
01.05.20	Shot Roster: COVID-19 Vaccines In Human Trials (RTTNews)
28.04.20	Pfizer Reaffirms 2020 Financial Guidance - Quick Facts (RTTNews)
28.04.20	Pfizer Inc. Q1 adjusted earnings Beat Estimates (RTTNews)
28.04.20	PFIZER REPORTS FIRST-QUARTER 2020 RESULTS (Businesswire)
23.04.20	Pfizer Hosts Virtual-Only Annual Meeting of Shareholders (Businesswire)
22.04.20	BioNTech, Pfizer To Begin COVID-19 Clinical Trial In Germany (RTTNews)
09.04.20	BioNTech Discloses Addl Details Of Pfizer Collaboration On COVID-19 Vaccine (RTTNews)
09.04.20	Pfizer Advances Battle Against Coronavirus On Multiple Fronts - Quick Facts (RTTNews)
09.04.20	Pfizer and BioNTech Announce Further Details on Collaboration to Accelerate Global COVID-19 Vaccine Development (Businesswire)
09.04.20	Pfizer Advances Battle Against COVID-19 on Multiple Fronts (Businesswire)
09.04.20	BMY Awaits FDA Decision, LQDA On Watch, MNOV To Begin Clinical Trial In COVID-19 (RTTNews)
09.04.20	U.S. FDA Approves BRAFTOVI® (Encorafenib) in Combination with Cetuximab for the Treatment of BRAFV600E-Mutant Metastatic Colorectal Cancer (CRC) After Prior Therapy (Businesswire)
07.04.20	Pfizer to Hold Virtual-Only 2020 Annual Meeting of Shareholders (Businesswire)
06.04.20	Pfizer and The Pfizer Foundation Donate $40 Million in Charitable Grants, Expand Product Access and Mobilize Colleagues to Combat COVID-19 Pandemic (Businesswire)
02.04.20	Pfizer Receives European Approval for Oncology Biosimilar, RUXIENCE™ (rituximab) (Businesswire)
02.04.20	Susan Desmond-Hellmann Elected to Pfizer’s Board of Directors (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Alcon	76.62	0.39 %	K V
Part Grp Hldg	1’271.50	0.36 %	K V
Holcim	89.08	0.25 %	K V
Logitech Intl	74.82	-0.05 %	K V
Lonza Grp	540.60	-0.15 %	K V
UBS Group	27.82	-1.24 %	K V
Sika	223.10	-1.37 %	K V
Nestle	74.10	-1.49 %	K V
Swiss Re	129.60	-1.78 %	K V
Givaudan	3’961.00	-2.46 %	K V

mehr

18.12.24		Dow Jones-Handel aktuell: Dow Jones beendet den Mittwochshandel mit Verlusten
18.12.24		Pluszeichen in Europa: STOXX 50 letztendlich fester
18.12.24		Minuszeichen in Zürich: SMI legt letztendlich den Rückwärtsgang ein
18.12.24		Börse Zürich in Rot: SPI schliesst in der Verlustzone
18.12.24		Handel in Europa: Euro STOXX 50 präsentiert sich letztendlich fester
18.12.24		Freundlicher Handel in London: FTSE 100 notiert zum Ende des Mittwochshandels im Plus
18.12.24		Zuversicht in Frankfurt: Zum Ende des Mittwochshandels Pluszeichen im TecDAX
18.12.24		Aufschläge in Frankfurt: SDAX steigt zum Handelsende

18.12.24

Dow Jones-Handel aktuell: Dow Jones beendet den Mittwochshandel mit Verlusten

18.12.24

Pluszeichen in Europa: STOXX 50 letztendlich fester

18.12.24

Minuszeichen in Zürich: SMI legt letztendlich den Rückwärtsgang ein

18.12.24

Börse Zürich in Rot: SPI schliesst in der Verlustzone

18.12.24

Handel in Europa: Euro STOXX 50 präsentiert sich letztendlich fester

18.12.24

Freundlicher Handel in London: FTSE 100 notiert zum Ende des Mittwochshandels im Plus